Potential role of retina as a biomarker for progression of Parkinson's disease
- PMID: 22553695
- PMCID: PMC3340867
- DOI: 10.3980/j.issn.2222-3959.2011.04.21
Potential role of retina as a biomarker for progression of Parkinson's disease
Abstract
Optical coherence tomography (OCT) noninvasively quantifies the thickness of the retinal nerve fiber layer (RNFL). OCT has been studied in several neuro-ophthalmic conditions, including Parkinson's disease (PD). Recent studies suggest that the quantitative analysis of RNFL can be precisely and noninvasively done by OCT scans and the results suggest that the thickness of RNFL is significantly decreased in patients with PD compared with age-matched controls and the foveal retinal thickness correlates with disease severity in PD. In this article, the application of OCT imaging of the retina in PD was reviewed. Literature survey of PubMed was carried out using the search terms of "Optical Coherence Tomography" combined with "Parkinson's Disease" and "retinal nerve fiber layer" (without restriction to the year of publication). Some related articles were also included. The search was completed in Jul. 2011 and revised and updated as necessary. The aim of this article is to review the current literatures on the use of optical coherence tomography in patients affected by PD and to enhance its use in clinical practice in neuro-ophthalmology.
Keywords: Parkinson disease; optical coherence tomography; retinal nerve fiber layer thickness.
Similar articles
-
Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease.Parkinsonism Relat Disord. 2015 Oct;21(10):1164-9. doi: 10.1016/j.parkreldis.2015.08.002. Epub 2015 Aug 10. Parkinsonism Relat Disord. 2015. PMID: 26297381
-
Progressive Changes in the Retinal Structure of Patients with Parkinson's Disease.J Parkinsons Dis. 2018;8(1):85-92. doi: 10.3233/JPD-171184. J Parkinsons Dis. 2018. PMID: 29480221
-
Development of a prediction formula of Parkinson disease severity by optical coherence tomography.Mov Disord. 2014 Jan;29(1):68-74. doi: 10.1002/mds.25747. Epub 2013 Nov 14. Mov Disord. 2014. PMID: 24458320
-
Optical coherence tomography in Parkinson's disease: is the retina a biomarker?J Parkinsons Dis. 2014;4(2):197-204. doi: 10.3233/JPD-130306. J Parkinsons Dis. 2014. PMID: 24518436 Review.
-
Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies.Parkinsonism Relat Disord. 2019 Jul;64:40-49. doi: 10.1016/j.parkreldis.2019.04.023. Epub 2019 Apr 30. Parkinsonism Relat Disord. 2019. PMID: 31054866 Review.
Cited by
-
Assessment of Optical Coherence Tomography Findings in Adults with Attention Deficit Hyperactivity Disorder: A Case-Control Study.Psychiatry Clin Psychopharmacol. 2021 Dec 1;31(4):370-378. doi: 10.5152/pcp.2021.21183. eCollection 2021 Dec. Psychiatry Clin Psychopharmacol. 2021. PMID: 38765643 Free PMC article.
-
Assessment of the retinal nerve fiber layer in individuals with obstructive sleep apnea.BMC Ophthalmol. 2016 Apr 18;16:40. doi: 10.1186/s12886-016-0216-2. BMC Ophthalmol. 2016. PMID: 27090783 Free PMC article.
-
When Sex Matters: Differences in the Central Nervous System as Imaged by OCT through the Retina.J Imaging. 2023 Dec 25;10(1):6. doi: 10.3390/jimaging10010006. J Imaging. 2023. PMID: 38248991 Free PMC article.
-
Optical coherence tomography findings in Parkinson's disease.Kaohsiung J Med Sci. 2018 Mar;34(3):166-171. doi: 10.1016/j.kjms.2017.11.006. Epub 2017 Dec 6. Kaohsiung J Med Sci. 2018. PMID: 29475464 Free PMC article.
-
The Place of Optical Coherence Tomography in Patients with Obsessive Compulsive Disorder.Eurasian J Med. 2019 Oct;51(3):237-241. doi: 10.5152/eurasianjmed.2019.18306. Eurasian J Med. 2019. PMID: 31692778 Free PMC article.
References
-
- Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839–840. - PubMed
-
- Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B. Smith EO, Charney DS, Hoffer PB, Innis RB. Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol. 1995;38(4):589–598. - PubMed
-
- Brücke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wöber C, Müller C, Podreka I. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl. 1997;50(1):9–24. - PubMed
-
- Péran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Démonet JF, Stefani A, Pierantozzi M, Pontieri FE, Caltagirone C, Spalletta G, Sabatini U. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain. 2010;133(11):3423–3433. - PubMed
-
- Schuman JS, Hee MR, Arya AV, Pedut-Kloizman T, Puliafito CA, Fujimoto JG, Swanson EA. Optical coherence tomography: a new tool for glaucoma diagnosis. Curr Opin Ophthalmol. 1995;6(2):89–95. - PubMed
LinkOut - more resources
Full Text Sources